Obesity in Youth
Clinical research is centered on adipositas in children and adolescents, with attention to excess weight management in a paediatric population.
- Paediatric obesity
- Adolescent weight management
- Metabolic health
The sponsor’s current activity focuses on obesity care within a clinical pharmacology setting in Copenhagen, Denmark.
Psychiatric Treatment-Associated Metabolic Effects
Research interest includes antipsychotic-related weight gain and the metabolic burden associated with psychiatric medication in younger patients.
- Antipsychotic-associated obesity
- Medication-related weight gain
- Metabolic complications
This area links mental health treatment with body weight and metabolic outcomes in routine care.
GLP-1 Receptor Agonist Therapy
The sponsor is involved in evaluating GLP-1 receptor agonists as a therapeutic option for obesity management alongside standard care.
- GLP-1-RA treatment
- Anti-obesity pharmacotherapy
- Clinical pharmacology
Interest is directed toward the use of incretin-based therapy in a paediatric and adolescent setting.
